FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease ...Middle East

SILVER SPRING, Md., Dec. 18, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute graft-versus-host...

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease )

Also on site :

• Today’s NYT ‘Strands’ Hints, Spangram and Answers for Monday, June 9
• Israel Detains Greta Thunberg, Other Activists After Halting Gaza-Bound Aid Ship
• Israel blocks Greta Thunberg’s ship from reaching Gaza, group says